Fatty liver disease (MASLD/MASH) trials in United States
101 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleEndoscopic Ultrasound Shear Wave Elastography Study
- Where
- Boston, Danville, Newport Beach
- Age
- 18 years and over
- People
- 300
- Run by
- Olympus Corporation of the Americas
See details and how to joinNCT06592820 - No phaseNot yet taking people in United StatesIsocaloric Navy-Bean Substitution in Adults With MASLD
- Where
- New York
- Age
- 18 years to 75 years
- People
- 40
- Run by
- Icahn School of Medicine at Mount Sinai
See details and how to joinNCT07730853 - No phaseTaking peopleNAFLD Clinical Care Pathway
- Where
- Houston
- Age
- 18 years to 80 years
- People
- 32
- Run by
- VA Office of Research and Development
See details and how to joinNCT06671886 - Phase 2Taking peopleA Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
- Where
- Akron, Apple Valley, Austin, Bellaire, Bradenton, Brownsville, Chandler, Columbia, Cordova, Corpus Christi, Covington, Dayton, Decatur, Edinburg, Farmers Branch, Fayetteville, Forney, Fort Worth, Fountain Valley, Garland, Georgetown, Glenview, Greenbelt, Gurnee, Houma, Houston, Jupiter, La Jolla, Lancaster, Las Vegas, Little Rock, Long Beach, Marietta, Marlton, Marrero, Metairie, Miami, Miami Lakes, Monroe, Ocala, Orange, Pasadena, Peoria, Port Orange, Richmond, San Antonio, Shreveport, South Bend, Sparta, Springboro, St Louis, Sugar Land, Tucson, Victorville, Viera, Waco, Webster, Westlake, West Monroe, West Palm Beach, Wichita Falls
- Age
- 18 years to 75 years
- People
- 160
- Run by
- Eccogene
See details and how to joinNCT07288138 - Phase 2Taking peopleStudy to Evaluate ALN-CIDEB in Adults With Fibrotic Metabolic Dysfunction-Associated Steatohepatitis (MASH)
- Where
- Arlington, Austin, Dallas, Danville, Doral, Fort Myers, Georgetown, Houston, Indianapolis, Marrero, Metairie, Miami, Nashville, Pasadena, Rialto, San Antonio, Sugar Land, Topeka, Tucson
- Age
- 18 years to 75 years
- People
- 360 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT07631637 · EU 2026-525916-33-00 - Phase 3Taking peopleA Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
- Where
- Amarillo, Atlanta, Aurora, Austin, Baltimore, Bastrop, Bellaire, Birmingham, Bradenton, Brandon, Brownsville, Buffalo, Chandler, Chapel Hill, Charleston, Charlotte, Chattanooga, Chicago, Chula Vista, Clarksville, Colorado Springs, Columbia, Columbus, Conway, Coronado, Corpus Christi, Covington, Dallas, Dayton, Denison, Doral, Dothan, Durham, Edinburg, Englewood, Escondido, Falls Church, Fayetteville, Flagstaff, Florham Park, Flowood, Folsom, Forney, Fort Myers, Fort Worth, Gainesville, Glen Burnie, Greenbelt, Hammond, Hermitage, Hershey, Hialeah Gardens, Houma, Houston, Indianapolis, Inglewood, Inverness, Jackson, Jacksonville, Jonesboro, Kansas City, Lady Lake, Lakewood Rch, La Mesa, Lancaster, Largo, Las Vegas, Lehigh Acres, Lewisville, Little Rock, Long Beach, Los Angeles, Louisville, Madison, Maitland, Manhasset, Margate, Marietta, Marrero, McAllen, Metairie, Miami, Miami Gardens, Miami Lakes, Morehead City, Naples, Nashville, New Bedford, New Bern, New Haven, New Orleans, Newport Beach, Newport News, New Port Richey, New York, Norfolk, North Little Rock, Novi, Ocala, Ogden, Orange, Orlando, Palm Springs, Pasadena, Pembroke Pines, Peoria, Philadelphia, Pittsburgh, Port Orange, Raleigh, Redwood City, Reno, Richmond, Ridgewood, Riverview, Roanoke, Rochester, Sacramento, Salt Lake City, San Antonio, San Diego, Sandy City, San Francisco, San Marcos, Santa Fe, Santa Maria, Sarasota, Seattle, Shreveport, Somers Point, South Bend, Southfield, South Ogden, Sparta, Spokane, Springboro, Statesville, St Louis, Suffolk, Summerville, Temple Terrace, Topeka, Tucson, Venice, Viera, Waco, Washington D.C., Webster, West Des Moines, Westlake, West Monroe, Weston, West Palm Beach, Wichita, Wichita Falls, Winter Park, Wyoming, Ypsilanti, Zephyrhills
- Age
- 18 years to 80 years
- People
- 1,650 worldwide
- Run by
- Akero Therapeutics, Inc
See details and how to joinNCT06215716 - Phase 2Taking peopleA Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
- Where
- Austin, Baltimore, Chandler, Dallas, Fayetteville, Fresno, Georgetown, Houston, Kansas City, Lancaster, Marietta, Mesa, Miami, New York, Pasadena, Pearland, Rialto, Richmond, San Antonio, Santa Maria, Tucson, Viera, Waco, Wilson
- Age
- 18 years to 75 years
- People
- 42
- Run by
- GlaxoSmithKline
See details and how to joinNCT06920043 - Phase 1Taking peopleA Study of Efimosfermin Alfa in Adults With Hepatic Impairment
- Where
- Houston, Miami Lakes, Rialto, San Antonio, Tampa
- Age
- 18 years to 70 years
- People
- 32
- Run by
- GlaxoSmithKline
See details and how to joinNCT07358546 - Phase 3Taking peopleA Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
- Where
- Arlington, Austin, Bellaire, Cape Coral, Dallas, Folsom, Fort Myers, Hialeah, Homestead, Humble, Kissimmee, Lakeland, Little Rock, Manassas, Miami, Morehead City, New York, Ocala, San Antonio, Santa Maria, St Louis, University Park, Waco, West Jordan, Westlake
- Age
- 18 years to 75 years
- People
- 1,740 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT07701993 - Phase 3Taking peopleA Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
- Where
- Arcadia, Arlington, Arroyo Grande, Austin, Bellaire, Cape Coral, Dallas, East Syracuse, Folsom, Fort Myers, Hialeah, Homestead, Houston, Humble, Kissimmee, Lakeland, Little Rock, Manassas, Miami, Morehead City, New York, Ocala, San Antonio, Springboro, St Louis, University Park, Van Nuys, Waco, West Jordan, Westlake
- Age
- 18 years to 75 years
- People
- 380 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT07704892 - Phase 3Taking peopleTrial to Evaluate ALN-CIDEB in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
- Where
- Georgetown, Marrero, Metairie, Miami
- Age
- 18 years to 75 years
- People
- 1,500
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT07854782 · EU 2026-526723-22-00 - Phase 3Not yet taking people in United StatesELEVATE-LIVER: A Study to Test Whether Survodutide Helps Improve Heart Structure and Function in People With Overweight or Obesity and Fatty Liver Disease
- Where
- Albuquerque, Boston, Bristol, Dallas, Durham, Kansas City, Los Angeles, Oxnard, Pasadena, Peoria, Statesville, Summerville, Topeka, University Park, West Hills
- Age
- 18 years and over
- People
- 600 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07850063 · EU 2026-527091-88-00 - Phase 3Taking peopleLIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
- Where
- Altamonte Springs, Arlington, Austin, Baltimore, Bastrop, Bellaire, Birmingham, Boston, Bradenton, Brandon, Bristol, Brooklyn, Brooksville, Brownsville, Canoga Park, Carrollton, Charleston, Chattanooga, Chesterfield, Chula Vista, Clarksville, Clearwater, Clermont, Clinton Township, Clive, Colorado Springs, Columbia, Columbus, Coral Gables, Coronado, Corpus Christi, Cutler Bay, Dallas, Denison, DeSoto, Durham, Edinburg, Englewood, Fayetteville, Flourtown, Flowood, Forney, Fort Myers, Fountain Valley, Fresno, Gainesville, Gardena, Garden City, Garland, Georgetown, Greenville, Hammond, Hershey, Hialeah, Hialeah Gardens, Homestead, Houston, Huntington Park, Inglewood, Kansas City, Lady Lake, Lakewood Rch, La Mesa, Lancaster, Las Vegas, Laurelton, Lewisville, Long Beach, Los Angeles, Macon, Maitland, Mansfield, Marrero, McAllen, Mentor, Miami, Miami Lakes, Minneapolis, Montclair, Naples, Nashville, New Bern, New Haven, Newport News, New York, Omaha, Orange, Orlando, Oxnard, Palmetto Bay, Pasadena, Pembroke Pines, Peoria, Plano, Port Orange, Poway, Raleigh, Rialto, Richmond, Riverdale, Riverview, Rochester, San Antonio, San Bernardino, San Diego, Santa Ana, Scottsdale, Seattle, Shreveport, South Bend, Spokane, Springboro, State College, St. Petersburg, Summerville, Tampa, The Villages, Topeka, Tucson, Tulsa, University Park, Van Nuys, Victorville, Waco, Warren Township, West Des Moines, Westlake, Wichita Falls, Winter Park, Wyoming, Wyomissing, Zephyrhills
- Age
- 18 years and over
- People
- 1,800 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT06632444 · EU 2024-513739-25-00 - Phase 3Taking peopleLIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
- Where
- Arlington, Atlanta, Austin, Bastrop, Bellaire, Bradenton, Brandon, Bristol, Brooklyn, Brooksville, Brownsville, Canoga Park, Chattanooga, Chula Vista, Clarksville, Clinton Township, Colorado Springs, Columbia, Columbus, Coral Gables, Coronado, Cutler Bay, Dallas, Denison, Englewood, Fayetteville, Flourtown, Fort Myers, Fountain Valley, Garden City, Garland, Georgetown, Greenville, Hammond, Hershey, Hialeah, Hialeah Gardens, Homestead, Houston, Huntington Park, Inglewood, Kansas City, Lady Lake, La Mesa, Lancaster, Las Vegas, Laurelton, Lewisville, Macon, Mansfield, Marrero, McAllen, Mentor, Miami, Miami Lakes, Minneapolis, Montclair, Nashville, New Port Richey, New York, Omaha, Orange, Orlando, Oxnard, Palmetto Bay, Pembroke Pines, Peoria, Poway, Raleigh, Rialto, Richmond, Riverdale, Riverview, Rochester, San Antonio, San Bernardino, San Diego, Scottsdale, Seattle, Shreveport, South Bend, Spokane, Springboro, St. Petersburg, Summerville, Tampa, The Villages, Tucson, Tulsa, University Park, Waco, Warren Township, West Des Moines, Westlake, Wichita Falls, Winter Park, Wyoming, Wyomissing, Zephyrhills
- Age
- 18 years and over
- People
- 1,590 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT06632457 · EU 2024-513741-36-00 - Phase 2Taking peopleNon-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
- Where
- Bethesda
- Age
- 18 years to 100 years
- People
- 104
- Run by
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
See details and how to joinNCT03884075 - No phaseTaking peopleEvaluation of Non-Invasive Tests for Metabolic Liver Disease
- Where
- Bellaire, Columbus, Miami, San Antonio
- Age
- 18 years to 75 years
- People
- 400
- Run by
- Foundation for the National Institutes of Health
See details and how to joinNCT07122700 - Phase 3Taking peopleA Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- Where
- Akron, Albany, Albuquerque, Amarillo, Athens, Austin, Baltimore, Bellaire, Bellevue, Birmingham, Brandon, Brownsville, Burlington, Canoga Park, Carmel, Chandler, Charleston, Charlotte, Chattanooga, Chesterfield, Chicago, Clermont, Cleveland, Colorado Springs, Columbia, Conway, Cordova, Coronado, Corpus Christi, Covington, Dalton, Dayton, Denton, DeSoto, Durham, East Greenwich, Edinburg, Escondido, Farmers Branch, Fayetteville, Flagstaff, Florham Park, Flowood, Fort Myers, Fort Sam Houston, Fort Worth, Fountain Valley, Freehold, Fresno, Gardena, Garland, Georgetown, Glen Burnie, Glendale, Greenbelt, Hammond, Hermitage, Hialeah Gardens, Homestead, Houma, Houston, Huntington Park, Inglewood, Iowa City, Jacksonville, Jupiter, Katy, Lady Lake, La Jolla, Lake Charles, Lakewood Rch, Lancaster, Las Vegas, Lehigh Acres, Lewisville, Liberty Township, Lima, Little Rock, Littleton, Long Beach, Los Angeles, Louisville, Lubbock, Maitland, Maplewood, Marietta, Marrero, Miami, Montclair, Morehead City, Nashville, New Albany, New Orleans, New Port Richey, New York, North Little Rock, Ocala, Ocoee, Ogden, Orange, Panorama City, Pasadena, Poway, Raleigh, Rialto, Richmond, Roanoke, Rochester, San Antonio, Santa Ana, Sarasota, Seattle, South Bend, Southlake, Springboro, Stafford, Stanford, St Louis, Sugar Land, Sun City, Tacoma, Tomball, Topeka, Tucson, Tyler, Victorville, Waco, Warren Township, Westlake, West Monroe, Wilmington, Winston-Salem, Winter Park, Wyoming, Ypsilanti
- Age
- 18 years to 80 years
- People
- 1,350 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT06318169 · EU 2023-509912-27-00 - Phase 3Taking peopleA Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- Where
- Akron, Albany, Albuquerque, Amarillo, Ann Arbor, Asheville, Athens, Atlanta, Austin, Baltimore, Bellevue, Birmingham, Brownsville, Burlington, Camarillo, Canoga Park, Chandler, Charleston, Charlotte, Chicago, Cincinnati, Clermont, Cleveland, Clinton Township, Columbia, Columbus, Cordova, Coronado, Dayton, DeSoto, Detroit, Durham, East Greenwich, Edinburg, Farmers Branch, Fayetteville, Flagstaff, Florham Park, Flowood, Fort Myers, Fort Worth, Fountain Valley, Framingham, Fresno, Gainesville, Georgetown, Glen Burnie, Glenview, Greenbelt, Greenville, Hammond, Harlingen, Hermitage, Hialeah Gardens, Homestead, Homewood, Houston, Huntington Park, Iowa City, Jacksonville, Kansas City, Lady Lake, Lafayette, La Jolla, Lake Charles, Lakewood Rch, Las Vegas, Lehigh Acres, Lewisville, Liberty Township, Little Rock, Littleton, Los Angeles, Louisville, Lubbock, Maitland, Mansfield, Marietta, Miami, Minneapolis, Nashville, New Albany, New Port Richey, New York, North Little Rock, Ocala, Ocoee, Orlando, Pasadena, Pearland, Peoria, Philadelphia, Phoenix, Pittsburgh, Poway, Rapid City, Redwood City, Rialto, Richmond, Rochester, Sacramento, San Antonio, Sandy City, San Marcos, Santa Ana, Seattle, Somers Point, South Bend, Southlake, St Louis, Sun City, Tacoma, Topeka, Tucson, Tupelo, Tyler, University Park, Viera, Waco, West Jordan, Westlake, West Monroe, Winston-Salem, Winter Park, Wyoming, Ypsilanti
- Age
- 18 years to 75 years
- People
- 1,800 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT06419374 · EU 2023-510395-31-00 - Phase 4Taking peopleOptimizing Portal Hypertension With TIPS and Interval Metabolic Surgery for Advanced Liver Disease
- Where
- Cleveland
- Age
- 18 years to 70 years
- People
- 70
- Run by
- The Cleveland Clinic
See details and how to joinNCT07058155 - No phaseEnrolling by invitationBiometabolic Outcomes After Weight Loss Surgery: An Individualized Approach
- Where
- Columbia
- Age
- 18 years to 80 years
- People
- 750
- Run by
- University of Missouri-Columbia
See details and how to joinNCT04841057 - Phase 1Taking peopleResmetirom in Patients With MASH and HFpEF
- Where
- Fort Myers, Oxnard, Peoria, Riverview, University Park
- Age
- 18 years and over
- People
- 90
- Run by
- Madrigal Pharmaceuticals, Inc.
See details and how to joinNCT07830758 - Phase 4Taking peopleRezdiffra® With Concomitant Therapies Commonly Used to Treat Comorbidities in Adults With MASH and F2-F3 Fibrosis
- Where
- Arlington, Chandler, Chattanooga, Cincinnati, Coronado, Corpus Christi, Dallas, Lake Charles, Lakewood Rch, McAllen, Miami, Morehead City, North Little Rock, Rialto, San Antonio
- Age
- 18 years and over
- People
- 150
- Run by
- Madrigal Pharmaceuticals, Inc.
See details and how to joinNCT07848191 - Phase 2Taking peopleA Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH)
- Where
- Arlington, Baltimore, Carrollton, Chandler, Charleston, Colorado Springs, Columbus, Coronado, Dallas, Fort Worth, Houston, Iowa City, Kansas City, La Mesa, Los Angeles, Miami, Miami Lakes, Montclair, Morehead City, Nashville, New York, Rochester, San Antonio, University Park
- Age
- 18 years to 75 years
- People
- 30 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07325526 - Phase 3Taking peopleA Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
- Where
- Akron, Amarillo, Arlington, Atlanta, Aurora, Austin, Baltimore, Bastrop, Bellaire, Bethesda, Birmingham, Bradenton, Brandon, Brownsville, Buffalo, Chandler, Chapel Hill, Charleston, Charlotte, Chicago, Clarksville, Clinton Township, Colorado Springs, Columbia, Conway, Coronado, Corpus Christi, Covington, Cutler Bay, Dallas, Daytona Beach, Denison, Doral, Dothan, Durham, Edinburg, Englewood, Escondido, Fayetteville, Flagstaff, Flowood, Folsom, Fort Myers, Fort Sam Houston, Fort Worth, Fountain Valley, Gainesville, Garland, Hammond, Henderson, Hermitage, Hershey, Hialeah Gardens, Houma, Houston, Indianapolis, Inverness, Jackson, Jonesboro, Kansas City, Kingwood, Lady Lake, Lafayette, Lakewood Rch, Lancaster, Largo, Las Vegas, Lehigh Acres, Little Rock, Long Beach, Los Angeles, Louisville, Madison, Manhasset, Margate, Marietta, Marrero, Metairie, Miami, Miami Gardens, Morehead City, Naples, Nashville, New Haven, Newport Beach, New Port Richey, New York, Norfolk, North Little Rock, Novi, Ocala, Oklahoma City, Orange, Orlando, Pasadena, Pembroke Pines, Peoria, Pharr, Philadelphia, Pittsburgh, Raleigh, Redwood City, Richmond, Riverview, Roanoke, Rochester, Sacramento, San Antonio, San Francisco, San Jose, Sarasota, Scottsdale, Seattle, Shreveport, Snellville, Somers Point, South Bend, South Dartmouth, Southfield, Sparta, Springboro, Statesville, St Louis, Sugar Land, Summerville, Tarzana, Temple Terrace, Topeka, Tucson, Vancouver, Venice, Viera, Waco, Washington D.C., Webster, West Des Moines, Westlake, West Monroe, Weston, Wichita Falls, Zephyrhills
- Age
- 18 years to 80 years
- People
- 2,150 worldwide
- Run by
- Akero Therapeutics, Inc
See details and how to joinNCT06528314 - No phaseNot yet taking people in United StatesAGED Diagnostics Clinical Validation Study
- Where
- Bethesda
- Age
- 18 years to 75 years
- People
- 500
- Run by
- Active Genomes Expressed Diagnostics, Corp
See details and how to joinNCT07867574